DK2278880T3 - Steroidbehandling af hedeture - Google Patents

Steroidbehandling af hedeture

Info

Publication number: DK2278880T3
Authority: DK; Denmark
Prior art keywords: hot flashes; steroid treatment; steroid; treatment; flashes
Prior art date: 2008-04-09

Application number

DK09729838.4T

Other languages

English (en)

Inventor

Louis Monti

Original Assignee

Pherin Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-09

Filing date

2009-04-09

Publication date

2012-11-12

2009-04-09 Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc

2012-11-12 Application granted granted Critical

2012-11-12 Publication of DK2278880T3 publication Critical patent/DK2278880T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

DK09729838.4T 2008-04-09 2009-04-09 Steroidbehandling af hedeture DK2278880T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12362208P	2008-04-09	2008-04-09
PCT/US2009/040102 WO2009126825A1 (en)	2008-04-09	2009-04-09	Steroid treatment for hot flashes

Publications (1)

Publication Number	Publication Date
DK2278880T3 true DK2278880T3 (da)	2012-11-12

Family

ID=41162250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09729838.4T DK2278880T3 (da)	2008-04-09	2009-04-09	Steroidbehandling af hedeture

Country Status (10)

Country	Link
US (2)	US20090258040A1 (da)
EP (1)	EP2278880B1 (da)
JP (1)	JP5524177B2 (da)
KR (1)	KR101602802B1 (da)
CN (1)	CN102056484B (da)
AU (1)	AU2009234159B2 (da)
BR (1)	BRPI0910637A2 (da)
DK (1)	DK2278880T3 (da)
MX (1)	MX2010011063A (da)
WO (1)	WO2009126825A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3648754A4 (en) *	2017-07-06	2021-05-05	Dignity Health	NEW TREATMENT FOR HEAT FLUSHING
CA3132489C (en) *	2019-04-15	2025-06-10	Pherin Pharmaceuticals, Inc.	MIGRAINE TREATMENT
WO2024254005A1 (en) *	2023-06-04	2024-12-12	Vistagen Therapeutics, Inc.	1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance
US20250312356A1 (en) *	2024-04-08	2025-10-09	Vistagen Therapeutics, Inc.	Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1158966B (de) *	1961-04-29	1963-12-12	Schering Ag	Verfahren zur Herstellung von 6-Chlor-1, 2ª-methylen-í¸-17ª-hydroxyprogesteronestern
US6140316A (en) *	1991-01-07	2000-10-31	Pherin Corporation	Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) *	1991-10-03	1994-04-19	Pherin Corporation	Combined neuroepithelial sample delivery electrode device and methods of using same
US6066627A (en) *	1994-08-04	2000-05-23	Pherin Corporation	Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) *	1994-08-04	1999-11-30	Pherin Corporation	Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6057439A (en) *	1994-08-04	2000-05-02	Pherin Corporation	Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5792757A (en) *	1994-08-04	1998-08-11	Pherin Pharmaceuticals	19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) *	1994-08-04	1996-10-08	Pherin Corporation	Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6331534B1 (en) *	1994-08-04	2001-12-18	Pherin Pharmaceuticals, Inc.	Steroids as neurochemical stimulators of the VNO to alleviate pain
US6117860A (en) *	1994-08-04	2000-09-12	Pherin Pharmaceuticals, Inc.	Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
AU726625B2 (en) *	1996-07-23	2000-11-16	Pherin Pharmaceuticals, Inc.	Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US6165504A (en) *	1998-09-23	2000-12-26	Barr Laboratories, Inc.	Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) *	1999-04-02	2003-09-02	Barr Laboratories, Inc.	Method for treating osteoporosis in castrated prostatic cancer patients
WO2000059920A2 (en) *	1999-04-06	2000-10-12	Akzo Nobel N.V.	Orally active 7.alpha.-alkyl androgens
US20030045514A1 (en) *	2001-05-03	2003-03-06	Louis Monti	17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) *	2005-04-01	2009-01-27	Bionovo, Inc.	Composition for treatment of menopause
DK3045182T3 (da) *	2005-11-14	2018-03-19	Teva Pharmaceuticals Int Gmbh	Antagonistantistoffer rettet mod calcitonin gen-relateret peptid til behandling af klynge-hovedpine
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy

2009
- 2009-04-09 JP JP2011504180A patent/JP5524177B2/ja active Active
- 2009-04-09 MX MX2010011063A patent/MX2010011063A/es active IP Right Grant
- 2009-04-09 CN CN200980121663.6A patent/CN102056484B/zh active Active
- 2009-04-09 EP EP09729838A patent/EP2278880B1/en active Active
- 2009-04-09 AU AU2009234159A patent/AU2009234159B2/en active Active
- 2009-04-09 US US12/421,421 patent/US20090258040A1/en not_active Abandoned
- 2009-04-09 DK DK09729838.4T patent/DK2278880T3/da active
- 2009-04-09 BR BRPI0910637-5A patent/BRPI0910637A2/pt not_active IP Right Cessation
- 2009-04-09 KR KR1020107025191A patent/KR101602802B1/ko active Active
- 2009-04-09 WO PCT/US2009/040102 patent/WO2009126825A1/en not_active Ceased
2011
- 2011-11-03 US US13/288,778 patent/US8431559B2/en active Active

Also Published As

Publication number	Publication date
EP2278880B1 (en)	2012-10-10
EP2278880A4 (en)	2011-08-10
EP2278880A1 (en)	2011-02-02
US20090258040A1 (en)	2009-10-15
JP5524177B2 (ja)	2014-06-18
HK1157142A1 (en)	2012-06-29
WO2009126825A1 (en)	2009-10-15
CN102056484B (zh)	2014-10-29
KR20110014147A (ko)	2011-02-10
KR101602802B1 (ko)	2016-03-11
US8431559B2 (en)	2013-04-30
CN102056484A (zh)	2011-05-11
BRPI0910637A2 (pt)	2015-07-28
AU2009234159B2 (en)	2013-12-19
US20120108558A1 (en)	2012-05-03
AU2009234159A1 (en)	2009-10-15
MX2010011063A (es)	2010-11-22
JP2011518136A (ja)	2011-06-23

Publication	Publication Date	Title
DK2350096T3 (da)	2020-03-02	Fremgangsmåder til behandling af hepatisk encephalopati
DK2222272T3 (da)	2013-02-11	Behandling af luftvejssygdom
DK2982696T3 (da)	2019-05-27	Behandling af akut lymfoblastær leukæmi
DK3192520T3 (da)	2019-05-27	Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2386171T3 (da)	2019-05-20	Tilpasning af overgivelsesparametre
DK2558105T3 (da)	2020-01-27	Bardoxolonmethyl til behandling af fedme
DK3289876T3 (da)	2022-10-10	Forbindelser til behandling af cancer
DK2417262T3 (da)	2015-06-22	Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser
BRPI0908026A2 (pt)	2015-07-21	Métodos para o tratamento de doenças do intestino
BRPI0917925A2 (pt)	2015-11-10	estimulação da liberação de hormônio da saciedade
DK2373927T3 (da)	2013-06-10	Behandling af forbrændingsgas fra affaldsbehandling
EP2391307C0 (en)	2025-04-02	PENILE IMPLANT
DK2382009T3 (da)	2013-01-28	Bestrålingsindretning
DK2262793T3 (da)	2012-10-15	Krystallinske former af nilotinib-hci
DK3124610T3 (da)	2019-06-11	Hbv-behandling
DK2111555T3 (da)	2013-09-02	Diagnosticering af præeklampsi
DK2252317T3 (da)	2014-07-14	Behandling af makuladegeneration
EP2472185A4 (en)	2014-12-10	HEATING DEVICE
DK2358714T3 (da)	2012-08-20	Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK3284820T3 (da)	2020-12-07	Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK2411009T3 (da)	2013-06-24	Terapeutiske anvendelser af quinazolindionderivater
DK2554171T3 (da)	2014-11-17	Fremgangsmåde til behandling af sygdomme
DK2117565T3 (da)	2012-11-19	Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2501381T3 (da)	2017-11-06	Behandling af atrieflimmer
DK2175849T3 (da)	2013-05-13	Behandling af melanomer